Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Organic Letters|November 9, 2002
Fluorous dimethyl sulfide: a convenient, odorless, recyclable borane carrierDavid Crich, Santhosh NeelamkavilOrganic Letters|July 19, 2002
Generation and trapping of alkene radical cations under nonoxidizing conditions: formation of six-membered rings by exo- and endo-mode cyclizationsDavid Crich, Santhosh NeelamkavilJournal of the American Chemical Society|June 26, 2003
Tandem polar/radical crossover sequences for the formation of fused and bridged bicyclic nitrogen heterocycles involving radical ionic chain reactions, and alkene radical cation intermediates, performed under reducing conditions: scope and limitationsDavid Crich, Krishnakumar Ranganathan, Santhosh Neelamkavil, et al.Journal of Medicinal Chemistry|June 10, 2005
Replacement of Phe6, Phe7, and Phe11 of D-Trp8-somatostatin-14 with L-pyrazinylalanine. Predicted and observed effects on binding affinities at hSST2 and hSST4. An unexpected effect of the chirality of Trp8 on NMR spectra in methanolSanthosh Neelamkavil, Byron Arison, Elizabeth Birzin, et al.ACS Medicinal Chemistry Letters|December 21, 2016
Design and Synthesis of P2-P4 Macrocycles Containing a Unique Spirocyclic Proline: A New Class of HCV NS3/4A InhibitorsFrancisco Velázquez, Mariappan Chelliah, Martin Clasby, et al.Bioorganic & Medicinal Chemistry Letters|April 29, 2020
Design and synthesis of novel proline based factor XIa selective inhibitors as leads for potential new anticoagulantsZahid Hussain, Andrew J Cooke, Santhosh Neelamkavil, et al.Bioorganic & Medicinal Chemistry Letters|June 13, 2020
Discovery of hydroxy pyrimidine Factor IXa inhibitorsCharles L Jayne, Teresa Andreani, Tin-Yau Chan, et al.RSC Medicinal Chemistry|August 6, 2021
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitorsAnmol Gulati, Charles S Yeung, Blair Lapointe, et al.Journal of Medicinal Chemistry|December 30, 2021
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 InhibitorsMitchell H Keylor, Anmol Gulati, Solomon D Kattar, et al.Journal of Medicinal Chemistry|December 8, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's DiseaseDavid A Candito, Vladimir Simov, Anmol Gulati, et al.Pageof 1